Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production

CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production

US Patent 12006367 · Granted Jun 11, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies that bind to OX40 and their uses2025
Antibodies that bind to OX40 and their uses2025
Antibodies that bind to OX40 and their uses2025
CD28/OX40 bispecific antibodies2025
Production of T cell retargeting hetero-dimeric immunoglobulins2024
Production of T cell retargeting hetero-dimeric immunoglobulins2024
Production of T cell retargeting hetero-dimeric immunoglobulins2024
Production of T cell retargeting hetero-dimeric immunoglobulins2023
Production of T cell retargeting hetero-dimeric immunoglobulins2023
Production of T cell retargeting hetero-dimeric immunoglobulins2023
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their 2023
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their 2023